Ventracor holders believed a man that wears a bow tie! Wedbush analyst Duane Nash said the six-month survival rate is "unprecedented," and that figure is more important than the blood clot rate. He said most of the blood clots occurred at a few trial sites where physicians were hesitant to prescribe high doses of aspirin. Aspirin reduces the risk of blood clots but can make excess bleeding more likely.
"Surgeons we have spoken to after this presentation now believe inadequate aspirin dosing to be the culprit, and appear wholeheartedly reassured that no inherent clotting problem exists with the HVAD," Nash said. "Surgeons we have spoken to after this presentation now believe inadequate aspirin dosing to be the culprit, and appear wholeheartedly reassured that no inherent clotting problem exists with the HVAD," Nash said.
HIN Price at posting:
$1.98 Sentiment: LT Buy Disclosure: Held